Form 4 for CNO CNO Financial Group, Inc.
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001438233-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-12 | 2026-02-10 | CNO | Zimpfer Matthew J. | GC | A - Grant | $27.54 | +39.7K | 307.9K | +15% | +$1.09M |
| D | 2026-02-12 | 2026-02-12 | CNO | Zimpfer Matthew J. | GC | M - OptEx | $21.06 | +31.0K | 338.9K | +10% | +$652.2K |
| D | 2026-02-12 | 2026-02-10 | CNO | Zimpfer Matthew J. | GC | F - Tax | $43.05 | -7,663 | 293.6K | -3% | -$329.9K |
| D | 2026-02-12 | 2026-02-12 | CNO | Zimpfer Matthew J. | GC | S - Sale+OE | $42.93 | -31.0K | 307.9K | -9% | -$1.33M |
| D | 2026-02-12 | 2026-02-12 | CNO | Zimpfer Matthew J. | GC | M - OptEx | $0.00 | -31.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | A | A | 25,384 | $43.05 | 301,300 | D | — | — | (F1) Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025. |
| 2 | Common | Common Stock | 2026-02-12 | M | A | 30,970 | $21.06 | 338,907 | D | — | — | |
| 3 | Common | Restricted Stock Units | 2026-02-10 | A | A | 14,300 | $0.00 | 307,937 | D | — | — | (F3) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries. |
| 4 | Common | Common Stock | 2026-02-10 | F | D | 7,663 | $43.05 | 293,637 | D | — | — | (F2) Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units. |
| 5 | Common | Common Stock | 2026-02-12 | S | D | 30,970 | $42.93 | 307,937 | D | — | — | (F5) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. (F6) Reflects the weighted average sale price. Shares were sold at prices ranging from $42.31 per share to $43.75 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-12 | M | D | 30,970 | $0.00 | 0 | D | $21.06 · — to 2027-02-23 | 30,970 Common Stock | (F7) One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020. |